Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug ...

Genetics or hormonal changes can pose challenges for losing weight, as you may know firsthand. Like many others struggling to ...

Did she gain the weight back? Here's what she says, plus more mindful takeaways for the reported 15 million Americans who understand how "incredible" this woman's blood sugar and weight management ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

Taking medications like Ozempic and Wegovy may lead to more hair loss than other weight loss drugs, new research found.

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

In the case of breast cancer, women with a higher BMI do have higher rates of recurrence compared to women in the "normal" ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new semaglutide ...